#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Malignant peritoneal neoplasm Severe myoclonic epilepsy of infancy Autoimmune disorder Endometrial adenocarcinoma Intracranial calcification Corneal neovascularisation Stevens-Johnson syndrome Alveolar rhabdomyosarcoma Uterine leiomyosarcoma Lymphangioma Cholangiosarcoma Gastroenteropancreatic neuroendocrine tumour disease Vascular malformation Spinal cord injury cervical Spinal cord injury More trials…

    Learn about Rare Diseases

    Inclusion body myositis – Basic Information Shprintzen-Goldberg syndrome – Basic Information Aicardi-Goutieres syndrome Methylmalonic acidaemia – Basic Information Progressive supranuclear palsy Congenital nephrogenic diabetes insipidus – Treatment Optic glioma – Basic Information Haemophilia B with anti factor IX – Basic Information Marginal zone lymphoma refractory – Trials in Disease Carcinoid syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Apg777 Lumasiran H2-Receptor Antagonists Melphalan POTASSIUM HYDROXIDE Treprostinil Cat Epithelia Semaglutide Buparlisib D5-Ethyl-Beta-D-Glucuronide Cloxacillin Sodium Oxybuprocaine Hydrochloride Atenolol Ds-3939A Lbl-007 Paracetamol Ph. Eur. Quetiapine Dactylis Glomerata Sodium Hyaluronate Fluoroethyltyrosine F-18 More therapies…

    Learn about Your Condition

    Syphilis Wheezing Myelofibrosis Lung cancer metastatic Incontinence Cortical dysplasia Vitiligo Mesothelioma Notalgia paraesthetica Systemic mastocytosis Intestinal infarction Pituitary tumour benign Mantle cell lymphoma recurrent Autoimmune hepatitis Catatonia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Non-small cell lung cancer stage IV

  • Study on Durvalumab for Patients with Poor General Condition and Advanced Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • General physical health deterioration
    • Non-small cell lung cancer stage IV
    Investigated Drugs:
    • Durvalumab
    France

  • Study of Encorafenib and Binimetinib for Patients with BRAFV600E-Mutant Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage IV
    Investigated Drugs:
    • Binimetinib
    • Encorafenib
    France

  • Study on the Safety and Effectiveness of GB1211 and Atezolizumab for Patients with Non-Small Cell Lung Cancer

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage IIIB
    • Non-small cell lung cancer stage IV
    Investigated Drugs:
    • 5-Bromopyridin-3-Yl 3-Deoxy-1-Thio-3-[4-(3,4,5-Trifluorophenyl)-1H-1,2,3-Triazol-1-Yl]-Alfa-D-Galactopyranoside
    • Atezolizumab
    France Spain

  • Study Comparing Ensartinib and Crizotinib for Patients with ALK-Positive Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer recurrent
    • Non-small cell lung cancer stage IIIB
    • Non-small cell lung cancer stage IV
    Investigated Drugs:
    • Crizotinib
    • X-396
    Belgium Czechia France Italy The Netherlands Poland +1

  • Study of Tisotumab Vedotin, Pembrolizumab, and Platinum Drug Combination for Patients with Advanced or Metastatic Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Head and neck cancer metastatic
    • Head and neck cancer stage III
    • Head and neck cancer stage IV
    Investigated Drugs:
    • Tisotumab Vedotin
    • Carboplatin
    • Cisplatin
    France Germany Italy Spain

  • Study of Niraparib and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Niraparib Tosilate Monohydrate
    • Pembrolizumab
    Belgium Bulgaria France Germany Greece Hungary +8
Previous Page
1 … 4 5 6 7 8 … 10
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!